|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01873 VIVA BIOTECH
Nominal 
2.590 -0.110 (-4.074%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 831,874 | -15.273% | 981,824 | 1,142,184 | 1,108,747 | 1,026,451 |
| Cost of Sales | (492,447) | -23.376% | (642,679) | (736,216) | (763,775) | (710,176) |
| Gross Profit | 339,427 | 0.083% | 339,145 | 405,968 | 344,972 | 316,275 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 52,997 | -11.287% | 59,740 | 13,662 | (5,051) | 45,997 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (418) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 171,695 | -7.450% | 185,516 | 36,752 | (63,474) | 122,054 | |
| Taxation | (23,058) | -44.141% | (41,279) | (23,093) | (21,746) | (26,252) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (26,832) | -2.177% | (27,429) | (12,646) | (5,981) | (10,782) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 121,805 | 4.278% | 116,808 | 1,013 | (91,201) | 85,020 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,085 | -59.344% | 22,346 | 74,640 | 78,186 | 79,926 |
| Depreciation & Amortisation | 107,446 | 5.753% | 101,601 | 105,768 | 87,254 | 68,298 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 6.000 | 20.000% | 5.000 | 0.100 | -5.000 | 4.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.829 | -- | 1.753 | 1.665 | 1.775 | 1.726 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 121,805 |
| %Change | 4.278% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB 1.829 |